NFL Biosciences S.A.
ALNFL.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €14 | €19 | €23 | €12 |
| - Cash | €3 | €2 | €4 | €2 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €11 | €17 | €20 | €9 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | – | – | – | – |
| Gross Profit | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | – | – | – |
| EBITDA | -€2 | -€2 | -€1 | -€2 |
| % Margin | – | – | – | – |
| Net Income | -€2 | -€1 | -€1 | -€2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0.14 | -0.075 | -0.2 |
| % Growth | 0% | -85.7% | 62.3% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |